Skip to content

Portrait Mobile Monitoring Solution V2.0 External Evaluation

Portrait Mobile Monitoring Solution V2.0 External Evaluation

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07309809
Enrollment
50
Registered
2025-12-30
Start date
2026-07-01
Completion date
2026-10-01
Last updated
2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monitoring

Keywords

Continuous Monitoring

Brief summary

The purpose of this study is to collect and assess feedback from the users regarding the functionality and performance of the Portrait Mobile Monitoring Solution V2.0. In addition, this study aims to collect raw parameter data from the investigational devices for use in current and future Portrait Mobile development, including engineering purposes as deemed appropriate by the Sponsor.

Detailed description

Subjects will be enrolled from a general hospital ward to receive continuous monitoring for up to 72 hours by the Portrait Mobile Monitoring Solution V2.0. After the completion of that monitoring, both the clinician and the subject will complete a feedback survey about their experience with the device. The surveys along with raw data from the device will be collected from each subject.

Interventions

Subjects will have vital signs continuously monitored for up to 72 hours with the study device

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Participant is age 18 years or older (≥18 years). 2. Participant must have the ability to understand and provide written informed consent. 3. Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure. 4. Participant must be willing and able to comply with study procedures and duration.

Exclusion criteria

1. Known to be pregnant and/or breast feeding. 2. Diagnosed with infection requiring isolation. 3. Are immunocompromised. 4. Have previously participated in this study (no subject may participate more than once). 5. Subjects with Implantable Minute Ventilation Rate Responsive Pacemakers should be excluded from respiration rate monitoring.

Design outcomes

Primary

MeasureTime frameDescription
Collection of user feedback surveys from CliniciansUp to 72 hoursNumber of clinician feedback surveys collected at the end of each shift for clinicians overseeing care of subjects receiving continuous vital signs monitoring.
Collection of Subject Surveyup to 72 hoursNumber of subject surveys collected from study participants at the end of their continuous monitoring

Secondary

MeasureTime frameDescription
Collection of raw parameter data from Portrait Mobile Deviceup to 72 hoursCollection of electronic waveforms and device logs from the investigational device for the entire monitoring period for each subject.

Countries

United Kingdom

Contacts

CONTACTMeghan Terry
Meghan.Terry@gehealthcare.com262-290-6037

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026